• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C3a和C5a刺激人肥大细胞的趋化作用。

C3a and C5a stimulate chemotaxis of human mast cells.

作者信息

Hartmann K, Henz B M, Krüger-Krasagakes S, Köhl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T

机构信息

Department of Dermatology, Virchow Clinics, Humboldt University of Berlin, Germany.

出版信息

Blood. 1997 Apr 15;89(8):2863-70.

PMID:9108406
Abstract

The factors that control migration of mast cells to sites of inflammation and tissue repair remain largely undefined. Whereas several recent studies have described chemotactic factors that induce migration of murine mast cells, only stem cell factor (SCF) is known to induce migration of human mast cells. We report here that the anaphylatoxins C3a and C5a are chemotactic factors for the human mast cell line HMC-1, human cord blood-derived mast cells (CBMC) and cutaneous mast cells in vitro. The presence of an extracellular matrix protein, laminin, was required for chemotaxis in response to complement peptides. Migration of mast cells towards C3a and C5a was dose-dependent, peaking at 1 microg/mL (100 nmol/L), and was inhibited by specific antibodies. Pretreatment with pertussis toxin inhibited the anaphylatoxin-mediated migration of HMC-1 cells, indicating that Gi proteins are involved in complement-activated signal transduction pathways in human mast cells. Both C3a and C5a also induced a rapid and transient mobilization of intracellular free calcium ([Ca2+]i) in HMC-1 cells. Besides SCF, other chemotactic factors tested, such as interleukin-3, nerve growth factor, transforming growth factor beta, RANTES (regulated upon activation, normal Tcell expressed and secreted), monocyte chemotactic protein-1 (MCP-1), MCP-2, MCP-3, macrophage inflammatory protein-1alpha (MIP-1alpha), and MIP-1beta, failed to stimulate migration of human mast cells. In summary, these findings indicate that C3a and C5a serve as chemotaxins for human mast cells. Anaphylatoxin-mediated recruitment of mast cells might play an important role in hypersensitivity and inflammatory processes.

摘要

控制肥大细胞迁移至炎症和组织修复部位的因素在很大程度上仍不明确。尽管最近有几项研究描述了诱导小鼠肥大细胞迁移的趋化因子,但已知只有干细胞因子(SCF)能诱导人肥大细胞迁移。我们在此报告,过敏毒素C3a和C5a是体外人肥大细胞系HMC-1、人脐带血来源的肥大细胞(CBMC)和皮肤肥大细胞的趋化因子。响应补体肽的趋化作用需要细胞外基质蛋白层粘连蛋白的存在。肥大细胞向C3a和C5a的迁移呈剂量依赖性,在1微克/毫升(100纳摩尔/升)时达到峰值,并被特异性抗体抑制。百日咳毒素预处理可抑制过敏毒素介导的HMC-1细胞迁移,表明Gi蛋白参与人肥大细胞中补体激活的信号转导途径。C3a和C5a还能在HMC-1细胞中诱导细胞内游离钙([Ca2+]i)的快速短暂动员。除了SCF外,所测试的其他趋化因子,如白细胞介素-3、神经生长因子、转化生长因子β、调节激活正常T细胞表达和分泌的趋化因子(RANTES)、单核细胞趋化蛋白-1(MCP-1)、MCP-2、MCP-3、巨噬细胞炎性蛋白-1α(MIP-1α)和MIP-1β,均未能刺激人肥大细胞迁移。总之,这些发现表明C3a和C5a是人肥大细胞的趋化因子。过敏毒素介导的肥大细胞募集可能在超敏反应和炎症过程中起重要作用。

相似文献

1
C3a and C5a stimulate chemotaxis of human mast cells.C3a和C5a刺激人肥大细胞的趋化作用。
Blood. 1997 Apr 15;89(8):2863-70.
2
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.C3a和C5a是人类肥大细胞的趋化因子,通过百日咳毒素敏感的信号转导途径,经不同受体发挥作用。
J Immunol. 1996 Aug 15;157(4):1693-8.
3
Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.人肥大细胞系HMC-1上C3a高亲和力和低亲和力受体的表达
Eur J Immunol. 1996 Apr;26(4):753-8. doi: 10.1002/eji.1830260405.
4
Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein.补体片段C3a通过对百日咳毒素敏感的G蛋白刺激中性粒细胞中的钙离子内流。
Eur J Biochem. 1993 Oct 1;217(1):289-94. doi: 10.1111/j.1432-1033.1993.tb18245.x.
5
Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.C3a和C5a过敏毒素刺激后人星形细胞瘤中细胞因子的表达:白细胞介素-6 mRNA表达特异性增加。
J Neurochem. 1999 Jun;72(6):2426-36. doi: 10.1046/j.1471-4159.1999.0722426.x.
6
Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.白细胞介素-33 增强补体过敏毒素诱导的人肥大细胞活性。
Front Immunol. 2021 Feb 1;11:615236. doi: 10.3389/fimmu.2020.615236. eCollection 2020.
7
Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.补体肽C3a和C5a诱导人皮肤肥大细胞解离后介质释放。
J Invest Dermatol. 1994 May;102(5):803-6. doi: 10.1111/1523-1747.ep12378589.
8
Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response.证明血小板活化因子能够激活肥大细胞并诱导趋化反应。
Immunology. 2000 Feb;99(2):314-9. doi: 10.1046/j.1365-2567.2000.00972.x.
9
Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells.C4a 通过 Gi 蛋白-腺苷酸环化酶抑制途径抑制肥大细胞中其他过敏毒素趋化作用和分泌作用。
Int Immunopharmacol. 2012 Jan;12(1):158-68. doi: 10.1016/j.intimp.2011.11.006. Epub 2011 Dec 7.
10
Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.细胞外信号调节激酶和磷脂酰肌醇-3激酶对人肥大细胞中C3a诱导的MCP-1/CCL2和RANTES/CCL5产生的不同调节作用
Mol Immunol. 2005 Mar;42(5):581-7. doi: 10.1016/j.molimm.2004.09.009.

引用本文的文献

1
The complement system in human pregnancy and preeclampsia.人类妊娠和子痫前期中的补体系统。
Front Immunol. 2025 Aug 19;16:1617140. doi: 10.3389/fimmu.2025.1617140. eCollection 2025.
2
Adaptation and Linguistic Validation of Angioedema PROMs in Latvian for Assessing Recurrent Angioedema.用于评估复发性血管性水肿的拉脱维亚语血管性水肿患者报告结局量表的改编与语言验证
J Clin Med. 2025 Feb 19;14(4):1375. doi: 10.3390/jcm14041375.
3
Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation.
急性髓系白血病中枢纽基因和免疫相关通路的鉴定:来自生物信息学和实验验证的见解
Front Immunol. 2025 Jan 10;15:1511824. doi: 10.3389/fimmu.2024.1511824. eCollection 2024.
4
Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia.补体激活作为肝素诱导的血小板减少症中血小板激活抗体的生物标志物。
J Thromb Haemost. 2025 Mar;23(3):1066-1076. doi: 10.1016/j.jtha.2024.12.015. Epub 2024 Dec 25.
5
MASTer cell: chief immune modulator and inductor of antimicrobial immune response.肥大细胞:主要免疫调节剂和抗菌免疫反应诱导剂。
Front Immunol. 2024 Apr 4;15:1360296. doi: 10.3389/fimmu.2024.1360296. eCollection 2024.
6
Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.理解和治疗糖尿病肾病的进展:聚焦于肾小管间质性炎症机制。
Front Endocrinol (Lausanne). 2023 Oct 4;14:1232790. doi: 10.3389/fendo.2023.1232790. eCollection 2023.
7
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics.从 bench 到 bedside:脂质纳米颗粒载体反应原性对推进核酸治疗的影响 。 (注:bench 和 bedside 在这里可能是特定语境下的术语,比如 bench 可能表示实验室研究阶段,bedside 表示临床应用阶段,可根据具体背景进一步准确理解,这里按字面翻译)
Pharmaceuticals (Basel). 2023 Jul 31;16(8):1088. doi: 10.3390/ph16081088.
8
Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target.补体作为急性呼吸窘迫综合征病理生物学连接组的重要枢纽:一个新兴的治疗靶点。
Front Immunol. 2023 Mar 17;14:1100461. doi: 10.3389/fimmu.2023.1100461. eCollection 2023.
9
The mast cell: A Janus in kidney transplants.肥大细胞:肾移植中的双面体。
Front Immunol. 2023 Feb 20;14:1122409. doi: 10.3389/fimmu.2023.1122409. eCollection 2023.
10
Local and Systemic Effects of Infection.感染的局部和全身效应
Microorganisms. 2023 Feb 13;11(2):470. doi: 10.3390/microorganisms11020470.